This is a StreetInsider.com Premium Only Page

Agenus (AGEN) –

Apr 17, 2024 06:51 AM Agenus Inc. (AGEN) PT Lowered to $35 at Baird

Apr 12, 2024 07:30 AM Agenus (AGEN) Reports Updated Phase 1 Data and Progress on BOT/BAL Development

Apr 12, 2024 07:30 AM Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer

Apr 8, 2024 02:59 PM Form 4 AGENUS INC For: Apr 05 Filed by: ARMEN GARO H

Apr 5, 2024 04:31 PM Agenus (AGEN) Announces 1:20 Reverse Stock Split

Apr 5, 2024 04:30 PM Agenus Announces Reverse Stock Split of Common Stock

Apr 5, 2024 04:20 PM Form 8-K AGENUS INC For: Apr 03

Apr 1, 2024 05:06 PM Form 4 AGENUS INC For: Apr 01 Filed by: Wright Timothy

Apr 1, 2024 04:24 PM Form 4 AGENUS INC For: Apr 01 Filed by: Hirsch Susan B

Apr 1, 2024 04:21 PM Form 4 AGENUS INC For: Apr 01 Filed by: WIINBERG ULF

Mar 25, 2024 09:21 AM Form 4 AGENUS INC For: Mar 22 Filed by: ARMEN GARO H

Mar 19, 2024 06:03 AM Form EFFECT AGENUS INC

Mar 18, 2024 09:54 AM Agenus Inc. (AGEN) PT Lowered to $5 at B.Riley

Mar 15, 2024 04:25 PM Form S-8 AGENUS INC

Mar 14, 2024 05:26 PM Form POS AM AGENUS INC

Mar 14, 2024 04:57 PM Form 10-K AGENUS INC For: Dec 31

Mar 14, 2024 04:54 PM Form POSASR AGENUS INC

Mar 14, 2024 07:32 AM Form 8-K AGENUS INC For: Mar 14

Mar 14, 2024 07:31 AM Agenus (AGEN) Misses Q4 EPS by 7c

Mar 14, 2024 07:30 AM Agenus Reports Fourth Quarter and Full Year 2023 Results

Mar 11, 2024 04:40 PM Form 4 AGENUS INC For: Mar 08 Filed by: ARMEN GARO H

Mar 6, 2024 07:32 AM Agenus (AGEN) Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024

Mar 6, 2024 07:30 AM Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024

Mar 5, 2024 04:30 PM Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 29, 2024 04:53 PM Form DEFA14A AGENUS INC

Feb 29, 2024 07:30 AM Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

Feb 27, 2024 08:58 AM Form 4 AGENUS INC For: Feb 23 Filed by: ARMEN GARO H

Feb 26, 2024 04:25 PM Form DEF 14A AGENUS INC For: Apr 03

Feb 26, 2024 07:30 AM Agenus to Participate in Leerink Partners Global Biopharma Conference

Feb 21, 2024 04:19 PM Form SC 13G AGENUS INC Filed by: Point72 Asset Management, L.P.

Feb 15, 2024 07:00 PM Form 4 AGENUS INC For: Feb 15 Filed by: ARMEN GARO H

Feb 15, 2024 08:03 AM Form PRE 14A AGENUS INC For: Apr 03

Feb 15, 2024 08:01 AM Form 8-K AGENUS INC For: Feb 15

Feb 15, 2024 07:02 AM Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design

Feb 14, 2024 08:33 AM Form SC 13G/A AGENUS INC Filed by: Deep Track Capital, LP

Feb 13, 2024 04:59 PM Form SC 13G/A AGENUS INC Filed by: VANGUARD GROUP INC

Feb 12, 2024 01:51 PM Form 4 AGENUS INC For: Feb 09 Filed by: ARMEN GARO H

Feb 12, 2024 07:03 AM Form 5 AGENUS INC For: Dec 31 Filed by: Hirsch Susan B

Feb 12, 2024 07:02 AM Form 5 AGENUS INC For: Dec 31 Filed by: Wright Timothy

Feb 9, 2024 05:12 PM Form SC 13G/A AGENUS INC Filed by: Artal International S.C.A.

Jan 31, 2024 08:00 AM Form 8-K AGENUS INC For: Jan 30

Jan 31, 2024 07:30 AM Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 29, 2024 12:29 PM Form 4 AGENUS INC For: Jan 26 Filed by: ARMEN GARO H

Jan 25, 2024 01:49 PM Form SC 13G/A AGENUS INC Filed by: BlackRock Inc.

Jan 22, 2024 12:03 PM Form SC 13G/A AGENUS INC Filed by: STATE STREET CORP

Jan 22, 2024 07:36 AM Agenus (AGEN) Announces Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI

Jan 22, 2024 07:30 AM Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population

Jan 16, 2024 04:19 PM Form 4 AGENUS INC For: Jan 12 Filed by: ARMEN GARO H

Jan 5, 2024 04:30 PM Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 4, 2024 07:30 AM Agenus to Participate in B. Riley Healthcare Conference